rs121913279, PIK3CA

N. diseases: 62
Source: BEFREE ×
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Colorectal Carcinoma
CUI: C0009402
Disease: Colorectal Carcinoma
1186 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.820 1.000 2 2005 2016
Neoplasms
CUI: C0027651
Disease: Neoplasms
1571 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.800 0.909 21 2006 2019
Malignant neoplasm of breast
CUI: C0006142
Disease: Malignant neoplasm of breast
2154 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.800 1.000 19 2006 2019
Mammary Neoplasms
CUI: C1458155
Disease: Mammary Neoplasms
78 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.740 1.000 4 2004 2016
Liver carcinoma
CUI: C2239176
Disease: Liver carcinoma
769 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.730 1.000 3 2008 2019
Adenocarcinoma of lung (disorder)
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
183 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.710 1.000 1 2016 2017
Congenital macrodactylia
CUI: C0265552
Disease: Congenital macrodactylia
2 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.710 1.000 1 2013 2017
Malignant neoplasm of ovary
CUI: C1140680
Disease: Malignant neoplasm of ovary
246 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.710 1.000 1 2004 2016
ovarian neoplasm
CUI: C0919267
Disease: ovarian neoplasm
229 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.710 1.000 1 2005 2016
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
2145 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.100 1.000 16 2006 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1441 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.090 1.000 9 2012 2018
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.080 1.000 8 2012 2018
Carcinogenesis
CUI: C0596263
Disease: Carcinogenesis
355 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.060 0.833 6 2012 2019
Neoplasm Metastasis
CUI: C0027627
Disease: Neoplasm Metastasis
327 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.030 0.667 3 2013 2019
Carcinoma
CUI: C0007097
Disease: Carcinoma
90 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.020 1.000 2 2011 2018
Hidradenoma Papilliferum
CUI: C0334348
Disease: Hidradenoma Papilliferum
5 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.020 1.000 2 2016 2017
Malignant neoplasm of colon and/or rectum
CUI: C4722085
Disease: Malignant neoplasm of colon and/or rectum
502 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.020 1.000 2 2013 2016
Mammary Tumorigenesis
CUI: C1512981
Disease: Mammary Tumorigenesis
5 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.020 1.000 2 2013 2016
Adenoma
CUI: C0001430
Disease: Adenoma
103 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2017 2017
Anaplasia
CUI: C0002793
Disease: Anaplasia
7 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2015 2015
Anaplastic thyroid carcinoma
CUI: C0238461
Disease: Anaplastic thyroid carcinoma
16 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2014 2014
Apocrine metaplasia
CUI: C0334036
Disease: Apocrine metaplasia
1 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2013 2013
Biliary Tract Cancer
CUI: C0750952
Disease: Biliary Tract Cancer
11 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2015 2015
Bladder Neoplasm
CUI: C0005695
Disease: Bladder Neoplasm
278 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2017 2017
Carcinoma breast stage IV
CUI: C0278488
Disease: Carcinoma breast stage IV
14 0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 0.010 1.000 1 2019 2019